GlassScriptPhysician profile
Neal D Daniel
NPI 1053525618
$12,128.59
in general payments reported to CMS, 2019-2025
50 companies · $2,687 in 2025
The $2,687 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,925 · 2020: $1,162 · 2021: $1,009 · 2022: $1,553 · 2023: $1,786 · 2024: $2,006 · 2025: $2,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,479.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,139.47 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,320.31 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $880.88 | 2019-2025 | Ofev, Jascayd |
| Mallinckrodt Hospital Products INC. | $836.85 | 2020-2025 | Acthar |
| Grifols USA, LLC | $746.17 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $646.74 | 2019-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $583.24 | 2019-2025 | Opsumit, Uptravi |
| Takeda Pharmaceuticals U.S.A., INC. | $559.31 | 2020-2025 | Glassia |
| Mylan Specialty L.P. | $351.79 | 2019-2024 | Yupelri |
| Philips North America LLC | $332.22 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Amgen INC. | $330.96 | 2021-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $311.34 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| United Therapeutics Corporation | $287.39 | 2019-2025 | Tyvaso, Tyvaso |
| Genentech USA, INC. | $277.55 | 2019-2020 | |
| Genzyme Corporation | $240.39 | 2020-2025 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $238.24 | 2019 | |
| Vifor Pharma, INC. | $182.18 | 2024-2025 | Zemaira |
| Csl Behring | $180.30 | 2020-2025 | Hizentra |
| Gilead Sciences, INC. | $161.03 | 2021-2023 | |
| Insmed, INC. | $140.30 | 2019-2025 | Brinsupri, Arikayce |
| Novartis Pharmaceuticals Corporation | $123.72 | 2019-2023 | |
| Axsome Therapeutics, INC. | $118.86 | 2023-2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $116.54 | 2020-2022 | |
| Viatris Specialty LLC | $114.35 | 2025 | Yupelri |
| Pfizer INC. | $114.04 | 2019-2024 | |
| Electromed, INC. | $87.64 | 2021-2024 | Smartvest |
| La Jolla Pharmaceutical Company | $84.44 | 2021-2024 | Giapreza |
| Ani Pharmaceuticals, INC. | $61.75 | 2023-2024 | Purified Cortrophin Gel |
| Inogen, INC. | $56.44 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen At Home Stationary Concentrator |
| Pulmonx Corporation | $43.50 | 2023-2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Allergan, INC. | $35.76 | 2020 | |
| Liquidia Technologies, INC. | $34.41 | 2025 | Yutrepia |
| Abbvie INC. | $32.28 | 2021-2023 | Avycaz |
| Janssen Pharmaceuticals, INC | $31.99 | 2020-2022 | |
| Astellas Pharma US INC | $30.86 | 2019-2023 | Cresemba |
| Harmony Biosciences LLC | $28.44 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $28.29 | 2021-2023 | Airduo Digihaler |
| Sunovion Pharmaceuticals INC. | $26.67 | 2019 | |
| Edwards Lifesciences Corporation | $25.64 | 2024 | Hemosphere |
| Inspire Medical Systems, INC. | $24.22 | 2025 | Inspire |
| Cook Medical LLC | $22.83 | 2019-2020 | |
| Ethicon INC. | $20.96 | 2025 | Monarch Platform |
| Getinge USA Sales, LLC | $19.64 | 2024 | Cardiosave Hybrid, Type B Plug |
| Melinta Therapeutics, LLC | $16.73 | 2023 | Vabomere, Rezzayo |
| Paratek Pharmaceuticals, INC. | $16.64 | 2021 | |
| Advanced Respiratory, INC | $15.14 | 2021 | |
| Baxter Healthcare | $14.16 | 2024 | Hillrom - Life 2000 Ventilation System |
| Hikma Pharmaceuticals USA | $13.91 | 2023 | Ryaltris |
| Cumberland Pharmaceuticals, INC. | $12.09 | 2019 | |
| Breas Medical, INC. | $9.99 | 2025 | Vivo 45 Ls |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neal Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.